The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Exacerbations of chronic obstructive pulmonary disease
Open accessAbstract
Exacerbations of chronic obstructive pulmonary disease are of major importance in terms of their prolonged detrimental effects on patients, the acceleration in disease progression and high healthcare costs. There is still debate about how exacerbations should be defined and graded, and their mechanisms are poorly understood. The major causal agents are either bacteria or viral infections, or a combination of the two. Noninfective causes include air pollution and pulmonary embolus but, in some patients, no cause is identified. Exacerbations represent an increase in the inflammation that is present in the stable state, with increased numbers of inflammatory cells (particularly neutrophils), cytokines, chemokines and proteases in the airways, and increased concentrations of certain cytokines and C-reactive protein in the blood. There are presently no reliable biomarkers with which to predict exacerbations. Exacerbations have a long-lasting adverse influence on health status. High doses of bronchodilators are the mainstay of treatment and systemic corticosteroids have some benefit. The routine use of antibiotics remains controversial but they are of benefit with exacerbations of a bacterial origin. Noninvasive ventilation is beneficial in preventing the need for intubation and its important complications but it is not certain whether its use in stable patients prevents exacerbations. Although important advances have been made, more effective treatments are needed in the future for prevention and treatment of exacerbations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citationRidker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Self-citationGlobal Initiative for Chronic Obstructive Lung Disease (GOLD)
Rahman, M. M., & Siddiqui, M. M. R. (2017) · Anwer Khan Modern Medical College Journal · doi:10.3329/akmmcj.v7i1.31596 · Cited by 3,106
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
Soler-Cataluna, J. J. (2005) · Thorax · doi:10.1136/thx.2005.040527 · Cited by 1,931
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationImmunology of asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2254 · Cited by 1,399
Self-citationThe Empirical Foundations of Telemedicine Interventions for Chronic Disease Management
Bashshur, R. L., Shannon, G. W., Smith, B. R., Alverson, D. C., Antoniotti, N., Barsan, W. G., Bashshur, N., Brown, E. M., Coye, M. J., Doarn, C. R., et al. (2014) · Telemedicine and e-Health · doi:10.1089/tmj.2014.9981 · Cited by 452
Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease
Thomsen, M., Ingebrigtsen, T. S., Marott, J. L., Dahl, M., Lange, P., Vestbo, J., & Nordestgaard, B. G. (2013) · JAMA · doi:10.1001/jama.2013.5732 · Cited by 401
Celli, B. R., Fabbri, L. M., Aaron, S. D., Agusti, A., Brook, R., Criner, G. J., Franssen, F. M. E., Humbert, M., Hurst, J. R., O’Donnell, D., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202108-1819pp · Cited by 371
Self-citationMacLeod, M., Papi, A., Contoli, M., Beghé, B., Celli, B. R., Wedzicha, J. A., & Fabbri, L. M. (2021) · Respirology · doi:10.1111/resp.14041 · Cited by 359
Self-citationBurgel, P.-R., Nesme-Meyer, P., Chanez, P., Caillaud, D., Carré, P., Perez, T., & Roche, N. (2009) · Chest · doi:10.1378/chest.08-2062 · Cited by 346
Lenferink, A., Brusse-Keizer, M., van der Valk, P. D., Frith, P. A., Zwerink, M., Monninkhof, E. M., van der Palen, J., & Effing, T. W. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011682.pub2 · Cited by 328
Mechanisms of cigarette smoke-induced COPD: insights from animal models
Churg, A., Cosio, M., & Wright, J. L. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00390.2007 · Cited by 319
Role of HDAC2 in the Pathophysiology of COPD
Barnes, P. J. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163257 · Cited by 318
Self-citationAirway Mucus: From Production to Secretion
Williams, O. W., Sharafkhaneh, A., Kim, V., Dickey, B. F., & Evans, C. M. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0436sf · Cited by 284
Wang, Z., Locantore, N., Haldar, K., Ramsheh, M. Y., Beech, A. S., Ma, W., Brown, J. R., Tal-Singer, R., Barer, M. R., Bafadhel, M., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3448oc · Cited by 274
Tele-assistance in chronic respiratory failure patients: a randomised clinical trial
Vitacca, M., Bianchi, L., Guerra, A., Fracchia, C., Spanevello, A., Balbi, B., & Scalvini, S. (2009) · European Respiratory Journal · doi:10.1183/09031936.00005608 · Cited by 264
Reactive Oxygen Species in Chronic Obstructive Pulmonary Disease
Boukhenouna, S., Wilson, M. A., Bahmed, K., & Kosmider, B. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5730395 · Cited by 259
Marciniuk, D. D., Brooks, D., Butcher, S., Debigare, R., Dechman, G., Ford, G., Pepin, V., Reid, D., Sheel, A. W., Stickland, M. K., et al. (2010) · Canadian Respiratory Journal · doi:10.1155/2010/425975 · Cited by 146
TNFα Antagonists for Acute Exacerbations of COPD: A Randomised Double-Blind Controlled Trial
Aaron, S. D., Vandemheen, K. L., Maltais, F., Field, S. K., Sin, D. D., Bourbeau, J., Marciniuk, D. D., FitzGerald, J. M., Nair, P., & Mallick, R. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202432 · Cited by 103
Metadata
- Authors
- Celli, B. R., & Barnes, P. J.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2007-05-31
- Volume
- 29
- Issue
- 6
- Pages
- 1224-1238
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2125522165
- Cited by
- 462
- References
- 149
- FWCI
- 25.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.